Immunocore Holdings plc ADR (NASDAQ:IMCR) Stock is trading Below -5.78% From 50-Day SMA
Leerink Partners raised the price target for the Immunocore Holdings plc ADR (NASDAQ:IMCR) stock to “an Outperform”. The rating was released on April 29, 2024, according to finviz. The stock was initiated by Robert W. Baird, who disclosed in a research note on October 31, 2023, to Outperform and set the price objective to $84. […]
The high-quality value of Immunocore Holdings plc ADR (IMCR) Stock is hidden beneath the surface
Leerink Partners raised the price target for the Immunocore Holdings plc ADR (NASDAQ:IMCR) stock to “an Outperform”. The rating was released on April 29, 2024, according to finviz. The stock was initiated by Robert W. Baird, who disclosed in a research note on October 31, 2023, to Outperform and set the price objective to $84. […]
It’s an all-out bull run for Immunocore Holdings plc ADR (IMCR) Stock
Leerink Partners raised the price target for the Immunocore Holdings plc ADR (NASDAQ:IMCR) stock to “an Outperform”. The rating was released on Apr-30-24, according to finviz. The stock was initiated by Robert W. Baird, who disclosed in a research note on October 31, 2023, to Outperform and set the price objective to $84. In their […]
JP Morgan Sets Immunocore Holdings plc ADR (NASDAQ:IMCR) Stock to “an Overweight”
JP Morgan raised the price target for the Immunocore Holdings plc ADR (NASDAQ:IMCR) stock to “an Overweight”. The rating was released on November 20, 2023, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $84. The stock was upgraded by JP Morgan, […]
